Homeβ€ΊSearchβ€ΊMiddle East Journal of Cancer

Middle East Journal of Cancer

Shiraz University of Medical Sciences Β· Iran Β· Est. 2010

ISSN2008-6709eISSN2008-6687
SJR Q4βœ“ WOS ESCIβœ“ Scopus / SJRβœ“ DOAJβœ“ Open Access
68
/ 100
Established
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
β—† WoS ESCI56
βœ“ Corroboration (2 more)+12
Total68
Third-party records Β· how this is calculated Β· Report an error β†’
⚑ Speed vs Prestige
How does this journal balance review speed with impact level?
14
weeks to publish Β· journal-reported
Average Β· vs ~15 wk median
Q4
SJR Rank
Bottom 25%
Impact Factor & Quartile Β· Web of Science (JCR)

βœ“ Indexed in the Web of Science Core Collection (ESCI) β€” Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page β†—

The Impact Factor & JCR quartile are licensed by Clarivate β€” we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q4. Source: Clarivate Journal Citation Reports.

SJR Scorei
0.192
H-Indexi
7
CiteScore
ViewΒ β†—
Scopus metric Β· on the journal’s page
SNIPi
0.152
Total Worksi
55
Total Citationsi
264
2yr Mean Citednessi
0.00
Open Impact Factor alternative

Aims & Scope

Middle East Journal of Cancer(MEJC) is an international peer-reviewed journal which aims to publish high-quality basic science and clinical research in the field of cancer. This journal will also reflect the current status of research as well as diagnostic and treatment practices in the field of cancer in the Middle East, where cancer is becoming a growing health problem. Lastly, MEJC would like to become a model for regional journals with an international outlook. Accordingly, manuscripts from authors anywhere in the world will be considered for publication. MEJC was developed to provide a forum for communicating original and novel research findings within the following fields:

General Information

Country / RegionIran
Primary LanguageEnglish
1st Year Published2010
FrequencyQuarterly
StatusActive (last: 2021)
Total Publications55
Publisher OrgShiraz University of Medical Sciences
Region🌍 Global South
OA Since2009
Visit Journal Website

Submission Info

Peer ReviewDouble-blind
Review Time~14 weeks
Acceptance Rateβ€”
OA LicenseCC BY
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes
Plagiarism Detectionβœ“ Yes

Think.Check.Submit Compliance

9/12 Β· 75%
βœ…
Do you know the journal / publisher?
Shiraz University of Medical Sciences
βœ…
Does the journal have a website?
βœ“ Linked
βœ…
Is the ISSN verified?
2008-6709 / 2008-6687
βœ…
Indexed in a trusted database?
WoS, Scopus, DOAJ
βœ…
Peer review process documented?
Double-blind
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
❌
Long-term digital preservation?
N/A
βœ…
Plagiarism detection in place?
Yes
βœ…
Listed in DOAJ (verified OA)?
DOAJ verified
βœ…
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
10
18
2011
3
25
2012
3
6
2013
7
49
2014
7
11
2015
3
0
2016
1
0
2017
2
3
2018

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category β€” its quartile can differ by discipline.

Cancer ResearchQ4
OncologyQ4

Subject Classification

Web of Science Categories

Oncology

Scopus Categories

Cancer ResearchOncology

Research Topics (OpenAlex)

Head and Neck Cancer StudiesAdvanced Radiotherapy TechniquesCancer Diagnosis and TreatmentGlioma Diagnosis and TreatmentBreast Cancer Treatment StudiesLymphoma Diagnosis and TreatmentSarcoma Diagnosis and TreatmentBladder and Urothelial Cancer TreatmentsGlobal Cancer Incidence and ScreeningHER2/EGFR in Cancer Research

Frequently asked questions about Middle East Journal of Cancer

Is Middle East Journal of Cancer a predatory journal?

PubScope has no integrity flags on record for Middle East Journal of Cancer: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 68/100. Indexing is a transparency signal, not a guarantee β€” always confirm fit and policies before submitting.

What is the impact factor of Middle East Journal of Cancer?

Middle East Journal of Cancer is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β€” including Arts & Humanities and Emerging Sources titles β€” receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date.

Is Middle East Journal of Cancer indexed in Scopus and Web of Science?

Middle East Journal of Cancer is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Middle East Journal of Cancer?

Middle East Journal of Cancer(MEJC) is an international peer-reviewed journal which aims to publish high-quality basic science and clinical research in the field of cancer. This journal will also reflect the current status of research as well as diagnostic and treatment practices in the field of cancer in the Middle East, where cancer is becoming a growing health problem. Lastly, MEJC would like to become a model for regional journals with an international outlook. Accordingly, manuscripts from authors anywhere in the world will be considered for publication. MEJC was developed to provide a fo

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref